Spiro and dispiro 1,2,4-trioxolane antimalarials

   
   

A means and method for treating malaria, schistosomiasis, and cancer using a spiro or dispiro 1,2,4-trioxolane is described. The preferred 1,2,4-trioxolanes include a spiroadamantane group on one side of the trioxolane group, and a spirocyclohexyl on the other side of the trioxolane group, whereby the spirocyclohexyl ring is preferably substituted at the 4-position. In comparison to artemisinin semisynthetic derivatives, the compounds of this invention are structurally simple, easy to synthesize, non-toxic, and potent against malarial parasites.

 
Web www.patentalert.com

< N-type calcium channel antagonists for the treatment of pain

< Process for preparing distamycin derivatives

> Preventives for the recurrence of cerebrovascular failure and agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof

> Compounds and compositions derived from olives and methods of the use thereof

~ 00187